Arcus Biosciences (RCUS) Short Interest Ratio & Short Volume → Elon’s New Device is About to Shock the World (From InvestorPlace) (Ad) Free RCUS Stock Alerts $16.15 +0.89 (+5.83%) (As of 05/9/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Arcus Biosciences Short Interest DataCurrent Short Volume6,840,000 sharesPrevious Short Volume8,250,000 sharesChange Vs. Previous Month-17.09%Dollar Volume Sold Short$111.42 millionShort Interest Ratio / Days to Cover8.3Last Record DateApril 15, 2024Outstanding Shares90,953,000 sharesFloat Size47,330,000 sharesShort Percent of Float14.45%Today's Trading Volume967,201 sharesAverage Trading Volume773,900 sharesToday's Volume Vs. Average125% Short Selling Arcus Biosciences ? Sign up to receive the latest short interest report for Arcus Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatRCUS Short Interest Over TimeRCUS Days to Cover Over TimeRCUS Percentage of Float Shorted Over Time Ad Gold Safe ExchangeGold Set to EXPLODE!Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.Click here now to download the free Precious Metals Buying Guide! Arcus Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20246,840,000 shares $111.42 million -17.1%14.5%8.3 $16.29 3/31/20248,250,000 shares $155.76 million +3.4%17.4%9.7 $18.88 3/15/20247,980,000 shares $151.78 million +3.9%16.9%9.3 $19.02 2/29/20247,680,000 shares $146.92 million +2.1%16.2%8.6 $19.13 2/15/20247,520,000 shares $123.37 million +7.4%15.9%8.6 $16.41 1/31/20247,000,000 shares $105.91 million -2.1%22.3%8.7 $15.13 Get the Latest News and Ratings for RCUS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Arcus Biosciences and its competitors with MarketBeat's FREE daily newsletter. 1/15/20247,150,000 shares $125.20 million -1.7%14.8%9.1 $17.51 12/31/20237,270,000 shares $138.86 million +7.4%15.1%9.6 $19.10 12/15/20236,770,000 shares $122.67 million +2.9%14.0%8.6 $18.12 11/30/20236,580,000 shares $99.09 million +9.3%13.7%9.1 $15.06 11/15/20236,020,000 shares $87.59 million -13.0%12.5%7.8 $14.55 10/31/20236,920,000 shares $108.68 million +0.6%14.4%8.3 $15.71 10/15/20236,880,000 shares $110.91 million +3.9%14.4%8.7 $16.12 9/30/20236,620,000 shares $118.83 million +1.4%13.8%8 $17.95 9/15/20236,530,000 shares $134.39 million -11.0%13.6%8 $20.58 8/31/20237,340,000 shares $150.47 million +2.5%15.5%7.4 $20.50 8/15/20237,160,000 shares $128.67 million -1.1%15.1%6.6 $17.97 7/31/20237,240,000 shares $144.08 million -6.7%15.2%6.8 $19.90 7/15/20237,760,000 shares $169.94 million -1.7%16.7%7.2 $21.90 6/30/20237,890,000 shares $160.25 million -18.1%16.9%7.3 $20.31 6/15/20239,630,000 shares $188.75 million -6.0%20.2%9 $19.60 5/31/202310,240,000 shares $210.33 million +18.0%21.5%9.6 $20.54 5/15/20238,680,000 shares $169.43 million +11.1%18.3%9 $19.52 4/30/20237,810,000 shares $139.41 million -3.2%16.6%8.4 $17.85 4/15/20238,070,000 shares $141.55 million +5.1%17.1%8.4 $17.54 3/31/20237,680,000 shares $140.08 million +15.1%16.4%7.6 $18.24 3/15/20236,670,000 shares $113.12 million -10.7%14.2%5.5 $16.96 2/28/20237,470,000 shares $136.03 million +14.8%15.9%6.4 $18.21 2/15/20236,510,000 shares $127.92 million +0.6%14.0%5.6 $19.65 1/31/20236,470,000 shares $139.95 million +1.3%14.0%5.5 $21.63 1/15/20236,390,000 shares $130.23 million -12.8%13.7%5.3 $20.38 12/30/20227,330,000 shares $151.58 million -2.5%15.7%6.6 $20.68 12/15/20227,520,000 shares $233.12 million -0.5%16.1%7.6 $31.00 11/30/20227,560,000 shares $265.89 million +7.7%16.2%9.6 $35.17 11/15/20227,020,000 shares $210.95 million +4.8%15.1%10.3 $30.05 10/31/20226,700,000 shares $170.72 million -19.1%15.0%9.8 $25.48 10/15/20228,280,000 shares $220.58 million +1.4%18.6%13 $26.64 9/30/20228,170,000 shares $213.73 million -3.1%18.3%12.8 $26.16 9/15/20228,430,000 shares $226.43 million -0.5%18.9%12.6 $26.86 8/31/20228,470,000 shares $203.96 million +3.2%19.0%12.1 $24.08Things Are Not Normal in America – Here’s What to Do (Ad)Get Out of the Dollar Before May 15 A Wall Street legend and our friend has just warned 896,000 Americans to prepare for May 15.This could be your solution. RCUS Short Interest - Frequently Asked Questions What is Arcus Biosciences' current short interest? Short interest is the volume of Arcus Biosciences shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 6,840,000 shares of RCUS short. 14.45% of Arcus Biosciences' shares are currently sold short. Learn More on Arcus Biosciences' current short interest. What is a good short interest ratio for Arcus Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RCUS shares currently have a short interest ratio of 8.0. Learn More on Arcus Biosciences's short interest ratio. Which institutional investors are shorting Arcus Biosciences? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Arcus Biosciences: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Arcus Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 14.45% of Arcus Biosciences' floating shares are currently sold short. Is Arcus Biosciences' short interest increasing or decreasing? Arcus Biosciences saw a drop in short interest in the month of April. As of April 15th, there was short interest totaling 6,840,000 shares, a drop of 17.1% from the previous total of 8,250,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Arcus Biosciences' float size? Arcus Biosciences currently has issued a total of 90,953,000 shares. Some of Arcus Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Arcus Biosciences currently has a public float of 47,330,000 shares. How does Arcus Biosciences' short interest compare to its competitors? 14.45% of Arcus Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Arcus Biosciences: ANI Pharmaceuticals, Inc. (1.01%), Kiniksa Pharmaceuticals, Ltd. (5.13%), Day One Biopharmaceuticals, Inc. (15.17%), Xencor, Inc. (10.09%), Morphic Holding, Inc. (12.48%), Protagonist Therapeutics, Inc. (6.00%), Akero Therapeutics, Inc. (11.83%), Ligand Pharmaceuticals Incorporated (4.98%), Dynavax Technologies Co. (14.17%), Ironwood Pharmaceuticals, Inc. (13.96%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Arcus Biosciences stock? Short selling RCUS is an investing strategy that aims to generate trading profit from Arcus Biosciences as its price is falling. RCUS shares are trading up $0.89 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Arcus Biosciences? A short squeeze for Arcus Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RCUS, which in turn drives the price of the stock up even further. How often is Arcus Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RCUS, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: ANIP Short Interest KNSA Short Interest DAWN Short Interest XNCR Short Interest MORF Short Interest PTGX Short Interest AKRO Short Interest LGND Short Interest DVAX Short Interest IRWD Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:RCUS) was last updated on 5/10/2024 by MarketBeat.com Staff From Our PartnersThe Crypto 9-5 Escape PlanCrypto 101 MediaGold Set to EXPLODE!Gold Safe ExchangeHe Is Giving Away BitcoinCrypto Swap ProfitsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward PressThe 2024 Gold Rush: Unleashing Market PotentialPriority Gold[URGENT] DO NOT Touch These AI Stocks!Weiss Ratings